Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Zevra Therapeutics (ZVRA) over the last 10 years, with Q3 2025 value amounting to 0.31%.

  • Zevra Therapeutics' Return on Invested Capital changed N/A to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year change of. This contributed to the annual value of 1.02% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zevra Therapeutics reported Return on Invested Capital of 0.31% as of Q3 2025.
  • Zevra Therapeutics' Return on Invested Capital's 5-year high stood at 0.54% during Q1 2021, with a 5-year trough of 1.85% in Q2 2024.
  • Its 5-year average for Return on Invested Capital is 0.35%, with a median of 0.15% in 2022.
  • As far as peak fluctuations go, Zevra Therapeutics' Return on Invested Capital crashed by -17700bps in 2024, and later surged by 17100bps in 2025.
  • Over the past 5 years, Zevra Therapeutics' Return on Invested Capital (Quarter) stood at 0.06% in 2021, then tumbled by -377bps to 0.17% in 2022, then dropped by 0bps to 0.17% in 2023, then crashed by -622bps to 1.21% in 2024, then skyrocketed by 74bps to 0.31% in 2025.
  • Its last three reported values are 0.31% in Q3 2025, 0.13% for Q2 2025, and 1.25% during Q1 2025.